The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Cognitive enhancement as a treatment for drug addictions
Open accessAbstract
Drug addiction continues to be an important public health problem, with an estimated 22.6 million current illicit drug users in the United States alone. For many addictions, including cocaine, methamphetamine, and marijuana addiction, there are no approved pharmacological treatments. Behavioral treatments are effective but effects vary widely across individuals. Treatments that are effective across multiple addictions are greatly needed, and accumulating evidence suggests that one such approach may be pharmacological or behavioral interventions that enhance executive inhibitory control in addicts. Current evidence indicates that most forms of chronic drug use may be associated with significant cognitive impairments, especially in attention, working memory, and response inhibition functions. In some studies, these impairments predict poor treatment retention and outcome. A number of cognitive enhancing agents, including galantamine, modafinil, atomoxetine, methylphenidate, and guanfacine, have shown promising findings in human studies. Specific behavioral interventions, including cognitive remediation, also show promise. However, whether improvement of selective cognitive functions reduces drug use behavior remains to be determined. Cognitive enhancement to improve treatment outcomes is a novel strategy worthy of future research, as are related questions such as whether these approaches may be broadly beneficial to most addicts or best reserved for substance users with specific demonstrated cognitive impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749
Hettema, J., Steele, J., & Miller, W. R. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143833 · Cited by 1,803
The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials
Burke, B. L., Arkowitz, H., & Menchola, M. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.5.843 · Cited by 1,575 · cited 1×
“For example, CBT, CM, and MI have been found to be effective across alcohol, cannabis, and cocaine use disorders (Burke et al., 2003; Dutra et al., 2008; Lussier et al., 2006; Marijuana Treatment Project Research Group, 2004; Miller and Wilbourne, 2002).”
BackgroundIndividual differences in executive functions are almost entirely genetic in origin.
Friedman, N. P., Miyake, A., Young, S. E., DeFries, J. C., Corley, R. P., & Hewitt, J. K. (2008) · Journal of Experimental Psychology: General · doi:10.1037/0096-3445.137.2.201 · Cited by 1,547
Impulsivity as a determinant and consequence of drug use: a review of underlying processes
de Wit, H. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00129.x · Cited by 1,415
Attentional bias in addictive behaviors: A review of its development, causes, and consequences
FIELD, M., & COX, W. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.030 · Cited by 1,376
A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders
Dutra, L., Stathopoulou, G., Basden, S. L., Leyro, T. M., Powers, M. B., & Otto, M. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111851 · Cited by 1,287
Cited by
Dong, G., & Potenza, M. N. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.005 · Cited by 559
Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis.
Smith, J. L., Mattick, R. P., Jamadar, S. D., & Iredale, J. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.009 · Cited by 546
Sex differences in stress-related alcohol use
Peltier, M. R., Verplaetse, T. L., Mineur, Y. S., Petrakis, I. L., Cosgrove, K. P., Picciotto, M. R., & McKee, S. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100149 · Cited by 413
Neuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 322
Cognitive Training in Mental Disorders: Update and Future Directions
Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13081075 · Cited by 318
Effects of non-invasive neurostimulation on craving: A meta-analysis
Jansen, J. M., Daams, J. G., Koeter, M. W. J., Veltman, D. J., van den Brink, W., & Goudriaan, A. E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.009 · Cited by 284
Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders
Blaine, S. K., & Sinha, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.037 · Cited by 257
“…of a return to drinking on a sensitized stress system have been broadly highlighted by the fact that treatment and laboratory studies have documented stress and negative mood as robust predictors of both medication response (Sofuoglu et al., 2013) and treatment outcome (Mulvaney et al., 1999).”
Connectome-based prediction of cocaine abstinence
Yip, S. W., Scheinost, D., Potenza, M. N., & Carroll, K. M. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101147 · Cited by 196
Self-citationThe Potential for Misuse and Abuse of Medications in ADHD: A Review
Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2801 · Cited by 198
Dong, G., Li, H., Wang, L., & Potenza, M. N. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.03.004 · Cited by 139
Internet interventions for adult illicit substance users: a meta‐analysis
Boumparis, N., Karyotaki, E., Schaub, M. P., Cuijpers, P., & Riper, H. (2017) · Addiction · doi:10.1111/add.13819 · Cited by 104
“CR interventions consist of various exercises intended to enhance cognitive skills such as problem-solving, attention, memory and abstract reasoning [74] 1 80”
BackgroundDong, G., Wang, Z., Wang, Y., Du, X., & Potenza, M. N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.009 · Cited by 99
Gender differences in subjective discontinuation symptoms associated with ketamine use
Chen, W.-Y., Huang, M.-C., & Lin, S.-K. (2014) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-9-39 · Cited by 87
“mine withdrawal symptoms and adverse effects is important, especially in cognitive deficits, because it associated with treatment retention and outcome in drug users [33].”
BackgroundDong, G., Lin, X., Hu, Y., Xie, C., & Du, X. (2015) · Scientific Reports · doi:10.1038/srep09197 · Cited by 76
Addiction, cognitive decline and therapy: Seeking ways to escape a vicious cycle
Perry, C. J., & Lawrence, A. J. (2017) · Genes, Brain and Behavior · doi:10.1111/gbb.12325 · Cited by 60
Maurage, P., de Timary, P., Billieux, J., Collignon, M., & Heeren, A. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12444 · Cited by 51
Associations between executive functions and problematic social networking sites use
Aydın, O., Obuća, F., Boz, C., & Ünal-Aydın, P. (2020) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2020.1798358 · Cited by 47
New Developments in Behavioral Treatments for Substance Use Disorders
Kiluk, B. D., & Carroll, K. M. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0420-1 · Cited by 45
“Cognitive enhancing interventions, such as computerized cognitive remediation, as well as newer pharmacologic agents, have recently gained greater attention as potential treatment targets and/or adjuncts to CBT [43].”
Self-citationFox, H., Sofuoglu, M., & Sinha, R. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114562464 · Cited by 30
Self-citationKiluk, B. D. (2019) · Perspectives on Behavior Science · doi:10.1007/s40614-019-00205-2 · Cited by 25
Zhao, W., Wei, T., Zhou, R., Wang, Y., Wang, Y., Ren, Z., Shao, W., Luo, H., Zhou, Y., Chen, N., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.713364 · Cited by 17
“Moreover, executive function can prevent the development of addiction by inhibiting impulsive and controlling behaviors, whilst degradation of executive function leads to an increase in impulsive behaviors and addiction development (16).”
Background
Metadata
- Authors
- Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 64
- Pages
- 452-463
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2055622849
- Cited by
- 298
- References
- 174
- FWCI
- 18.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.